Michael Logerfo

Michael Logerfo discloses dealings in Sagent Pharmaceuticals, Inc. to SEC (Form 4). The record holds 36 filings, for trades running from 20 April 2011 to 25 February 2016.

Market trades split into 2 purchases (€36k) and 8 sales (€474k). The net balance comes to €439k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 16 share grants and 6 option exercises.

Most recently, on 26 February 2016, the filings show a share grant worth €5,322 in Sagent Pharmaceuticals, Inc. The most recent open-market purchase was published on 18 May 2012, 5,288 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.